BlackRock Inc. - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$196,000
+988.9%
13,116
+769.2%
0.00%
Q1 2016$18,000
+80.0%
1,509
+142.6%
0.00%
Q4 2015$10,0000.0%6220.0%0.00%
Q3 2015$10,000
-33.3%
6220.0%0.00%
Q2 2015$15,000
+7.1%
6220.0%0.00%
Q1 2015$14,000
-33.3%
622
-25.4%
0.00%
Q4 2014$21,000
+10.5%
834
+34.1%
0.00%
Q3 2014$19,000
+18.8%
6220.0%0.00%
Q2 2014$16,000
+33.3%
622
+14.8%
0.00%
Q1 2014$12,000
-14.3%
5420.0%0.00%
Q4 2013$14,000
+27.3%
5420.0%0.00%
Q3 2013$11,0000.0%5420.0%0.00%
Q2 2013$11,0005420.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders